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nation process (Vacchio et al., 2007). 
Thus, the chronic inflammatory phe-
notype of Trex1-deficient mice could 
be the result of alterations in T cell 
development resulting in impaired 
function of the T cells that regulate 
self-tolerance in the immune system. 
Chimera experiments to test whether 
the immune phenotype of Trex1-defi-
cient mice is intrinsic to lymphocytes 
would be helpful in evaluating this 
and other related possibilities.
Thus, there are a startling number of 
ways that a defect in a DNA-process-
ing enzyme could impact the immune 
response. It is particularly compel-
ling that Trex1-deficient animals show 
no increase in mutation frequency or 
cancer incidence. This finding under-
scores the possibility that the primary 
biological role of Trex1 lies not in DNA 
repair but in the regulation of immu-
nity. It will be fascinating to see how 
the story resolves.
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The molecular pathways linking DNA-damage checkpoint proteins to cell-cycle progres-
sion remain largely unresolved. Findings by Ghavidel et al. (2007) reported in this issue 
suggest that tRNA trafficking and the transcription factor Gcn4 are key intermediates in the 
process by which yeast cells detect DNA damage and delay cell-cycle progression at the 
G1 to S phase transition.DNA damage leads to the activation 
of a DNA-damage checkpoint that 
halts cell-cycle progression and 
alters DNA replication and repair to 
maintain genome stability (Kastan 
and Bartek, 2004). In general, DNA 
damage is initially detected by 
checkpoint proteins that once acti-
vated modify other proteins involved 
in either cell-cycle progression 
or DNA repair or replication itself. 
However, many molecular pathways 
connecting checkpoint proteins 838 Cell 131, November 30, 2007 ©2007to events in the cell cycle remain 
unresolved, although at least some 
checkpoint proteins alter the cell-
cycle engine, for instance by regu-
lating cyclins and cyclin-dependent 
kinases (CDKs). Ghavidel et al. 
(2007) now explore the mechanisms 
underlying the delay in the G1 to S 
phase transition (called START in 
the budding yeast Saccharomy-
ces cerevisiae) in response to DNA 
damage. They provide surprising 
evidence that tRNA biogenesis and  Elsevier Inc.trafficking are linked to cell-cycle 
progression by indirectly regulating 
the translation of the cyclin Cln2.
START in S. cerevisiae, analogous 
to the restriction point in mamma-
lian cells, is the time in G1 when the 
cell monitors both growth status and 
genome integrity before committing 
to a round of cell division. Siede et 
al. (1993) were the first to observe 
that DNA damage in budding yeast 
causes a brief delay in the transi-
tion from G1 to S phase. Presumably 
even the brief delay allows for some 
(although incomplete) DNA repair 
to minimize the consequences of 
replication of a damaged template. 
Although the molecular pathways 
underlying these G1 controls remain 
to be resolved, G1 arrest after DNA 
damage does require checkpoint 
genes that impinge on CDK-cyclin 
activity (Sidorova and Breeden, 1997; 
Wysocki et al., 2006).
Ghavidel and colleagues hypoth-
esized that because defects in pro-
tein synthesis and DNA damage both 
cause a G1 delay at START, the two 
may share a common mechanism. 
The authors tie together four obser-
vations (Figure 1) that link DNA dam-
age and G1-S control. Their first and 
key observation is that DNA damage 
and Mec1 and Rad53 checkpoint 
proteins cause an accumulation of 
unspliced tRNAs in the nucleus. Of 
274 tRNA genes in yeast, 61 con-
tain introns that require pre-tRNA 
splicing in the cytoplasm (Yoshihisa 
et al., 2007). Ghavidel et al. used 
fluorescence in situ hybridization 
and northern analysis to show that 
DNA damage by MMS (an alkylat-
ing agent), by UV light, or by limited 
expression of a restriction enzyme in 
vivo increased the level of unspliced 
tRNAs in the nucleus. Next, Ghavidel 
et al. provide genetic evidence that 
Mec1 and Rad53 regulate the sub-
cellular distribution of Los1, a protein 
that exports tRNAs from the nucleus 
to the cytoplasm (Hopper and Phiz-
icky, 2003). Normally Los1 shuttles 
between the nucleus and cytoplasm, 
whereas after DNA damage Los1 is 
mainly in the cytoplasm, providing an 
explanation for the increased nuclear 
pools of intron-containing pre-tRNAs. 
Third, the authors provide a connec-
tion, albeit speculative, between 
unspliced tRNAs and the translation 
of the cyclin Cln2; they confirm that 
DNA damage causes a checkpoint 
gene-dependent increase in the syn-
thesis of Gcn4, a transcription factor 
that indirectly regulates translation 
after stress (Natarajan et al., 2001). 
Finally, the authors connect these 
events by showing that DNA damage, 
Los1, and Gcn4 all affect Cln2 trans-
lation as well as cell-cycle progres-sion. Most importantly, they provide 
evidence that gcn4 yeast mutants 
have a defect in the G1-S checkpoint 
and fail to inhibit Cln2 translation.
This series of observations led the 
authors to propose a surprising new 
pathway for cell-cycle control (Figure 
1). What is left unclear from the cur-
rent work is how Mec1 and Rad53 
regulate Los1 localization. It is also 
unclear whether unspliced nuclear 
tRNAs are indeed signaling interme-
diates as a “simple” version of the 
model posits, or if other aspects of 
tRNA (or another component) might 
be involved. Do other defects in tRNA 
processing activate a G1 delay by 
the same mechanism? Prior studies 
figure 1. tRnA Biogenesis and G1 Arrest
After DNA damage, the cell-cycle check-
point proteins Mec1 and Rad53 cause ac-
cumulation in the cytoplasm of the exportin 
protein Los1, which normally shuttles in and 
out of the nucleus. Cytoplasmic localization 
of Los1 after DNA damage, or Los1 deficien-
cy through mutation, causes an increase in 
unspliced tRNAs in the nucleus. Unspliced 
nuclear tRNAs, or some other entity, then 
activate translation of the transcription fac-
tor Gcn4. Gcn4 somehow activates a trans-
lational inhibitor of the cyclin Cln2, causing 
a delay in G1. In this version of the model, 
there are two pathways that lead from DNA 
damage to activation of Gcn4: one that is 
checkpoint gene dependent and regulates 
Gcn4 through Los1 and one that may be 
independent of canonical checkpoint genes 
(dotted line) and somehow regulates Gcn4 
or another factor downstream of Gcn4.Cell 131, Novshowed that a mutation in the 3′ ter-
minus of tRNAVal caused its nuclear 
accumulation, which induced Gcn4 
translation (Qiu et al., 2000). It is also 
not clear how unspliced or damaged 
nuclear tRNAs might activate Gcn4, 
whose translation is regulated by a 
pathway involving uncharged tRNAs 
and a second pathway that is less 
well-defined (Qiu et al., 2000). In this 
study, DNA damage did not appear to 
alter the level of mature tRNAs, and 
the level of uncharged tRNAs was not 
determined. It is also uncertain how 
Gcn4 might suppress Cln2 transla-
tion, although overproduction of Gcn4 
is known to decrease the transcription 
of ribosomal proteins and translation 
initiation factors (Natarajan et al., 
2001). It is possible that Cln2 (and its 
paralog Cln1) may be particularly sen-
sitive to the activation of Gcn4. Finally, 
it is unclear how other aspects of tran-
scriptional regulation and checkpoint 
gene function fit into this model of G1 
arrest (Wysocki et al., 2006).
Further inspection of the model high-
lights a striking observation made by the 
authors: Without DNA damage, yeast 
lacking los1 both accumulate unspliced 
nuclear tRNA and activate Gcn4; yet, 
these los1-deficient cells do not arrest 
in G1, and furthermore, los1 mutants 
show a robust G1 arrest after DNA 
damage. This presents a conundrum—
how are los1 mutants still responsive to 
DNA damage? What is equally surpris-
ing is that the arrest response in los1 
mutants no longer requires Rad53. 
The data taken together suggest to 
us that in wild-type cells DNA damage 
activates two pathways that are each 
required to regulate Cln2 translation 
and G1 arrest; one pathway requires 
checkpoint genes and the second one 
does not, and both converge on Gcn4 
(or something downstream from it) to 
regulate translation of Cln2. The nature 
of the second checkpoint gene-inde-
pendent pathway is unclear.
Uncertainties aside, this study 
provides evidence connecting tRNA 
trafficking and Gcn4 to DNA dam-
age, checkpoint proteins, and the 
cell-cycle machinery. Future work 
may address unresolved issues and 
determine the relevance of these find-
ings to vertebrate cells.ember 30, 2007 ©2007 Elsevier Inc. 839
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Apoptosis is important to sculpt 
tissues and eliminate unnecessary 
cells as well as for tumor suppres-
sion. However, mammalian devel-
opment is surprisingly intact in mice 
deficient in the essential proapop-
totic regulators Bax and Bak (Lind-
sten et al., 2000). Thus, in the 
absence of apoptosis, many types 
of developmental cell death can still 
occur by other mechanisms. For 
example, different pathways to cell 
death are involved in lumen forma-
tion in glandular epithelia. Indeed, 
cells with defective apoptosis can 
be diverted to necrotic cell death, 
but the roles of necrosis and per-
haps other modes of cell elimina-
tion in cancer and development are 
poorly understood. Reporting in 
this issue, Brugge and colleagues 
(Overholtzer et al., 2007) describe 
a new mode of nonapoptotic cell 
elimination called “entosis” that 
resembles cell cannibalism and the 
cell-in-cell phenotype observed in 
entosis: It’s a 
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some tumors. Their work provides 
yet another example of the fact that 
cell death is not just about apopto-
sis anymore.
In mammary epithelia, clearing of 
the lumen, which occurs for the pur-
pose of secretion, is a normal devel-
opmental process in puberty. Clear-
ing occurs when luminal cells that 
have detached from the ECM undergo 
a specialized form of apoptotic cell 
death termed anoikis. During anoikis, 
cells detach from the ECM and lose 
survival signaling through integrins 
(Gilmore, 2005). Luminal clearing has 
been studied in great detail because 
three-dimensional mammary epithe-
lial duct morphogenesis in the pres-
ence of an ECM can be modeled 
in vitro (Nelson and Bissell, 2006). 
Detachment from the ECM, or meta-
bolic or oxidative stress, triggers elim-
ination of these central acinar cells 
through caspase-dependent apop-
tosis or necrotic cell death if apop-
tosis is defective (Figure 1) (Debnath 
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Sha, F., and Kron, S.J. (2006). Nat. Struct. Mol. 
Biol. 13, 908–914.et al., 2002; Karantza-Wadsworth 
et al., 2007; Mailleux et al., 2007). In 
mammary acini, it is the acinar center 
where metabolic stress initiates the 
catabolic process of autophagy that 
sustains cell survival, which when 
inhibited can either accelerate apop-
tosis or induce necrotic cell death of 
apoptosis-defective cells (Figure 1) 
(Karantza-Wadsworth et al., 2007). 
Unregulated cell proliferation and 
decreased apoptosis in epithelial 
cancers such as those of breast are 
typified by filling of the lumen with 
cells. Therefore, identifying and char-
acterizing the various mechanisms 
for cell elimination in glandular epi-
thelia and establishing whether these 
events are deregulated in cancers, or 
can be reactivated therapeutically, is 
of great importance.
Upon examination of mammary 
epithelial cell lines in suspension, 
Overholtzer et al. noticed the pres-
ence of cells within other cells. Fur-
ther investigation of this phenom-
orld
nd Biochemistry, Rutgers University, 679 
y, Robert Wood Johnson Medical 
poptotic cell death pathway 
ached from the extracellular 
 is an event associated with 
poptosis—may contribute to 
lls.
